The superfamily of nuclear receptors comprises transcription factors that depend on a ligand for their activity. In addition, the superfamily includes a number of orphan receptors, for which no ligand is known. We report here that the orphan receptor estrogen receptor related alpha receptor (ERRa) stimulates the expression of the thyroid hormone receptor alpha (TRa) gene promoter. We characterized a responsive site that is both necessary and sucient for ERRa-induced transactivation. In addition, we show that both TRa and ERRa are coexpressed in embryonic intestine, brown fat and heart as well as in the adult gonads. In the testis, expression of both receptors can be found in the seminiferous tubes where it is totally restricted to spermatocytes I. Altogether this suggests that TRa is an in vivo target of ERRa.
Introduction
The thyroid hormone receptor alpha (TRa) belongs to the superfamily of nuclear receptors which comprises evolutionary conserved transcription factors whose activity depends on the presence of a ligand (Gronemeyer and Laudet, 1995) . Members of this superfamily include receptors for diverse hydrophobic ligands such as steroids, vitamin D, retinoids and fatty acids derivatives. In addition, the superfamily also includes several so-called orphan receptors, for which no ligand has been identi®ed to date (reviewed in Enmark and Gustafsson, 1996) . All nuclear receptors share the same organization features. Two protein domains are particularly important and were fairly well conserved along evolution. The so-called C domain directs the speci®c DNA-binding activity of the receptors. In the extreme C-terminal part of the protein, the E domain is responsible for various activities of the receptors including ligand recognition and ligand-dependent transactivation.
Two thyroid hormone receptor genes (a and b) have been identi®ed on the basis of their sequence similarity to the v-erbA gene encoded by the avian erythroblastosis retrovirus and hence originally named c-erbA 1 and 2 (Sap et al., 1986; Weinberger et al., 1986) . Unlike their viral homologue, the c-erbA gene products do not exert proliferative eects but are implicated in the induction of various dierentiation processes such as those of muscle cells (Carnac et al., 1993) , oligodendrocytes (Baas et al., 1997) and haematopoietic cells (Gandrillon et al., 1994) . Each of the TRa genes produce several mRNAs. In the case of TRa , two promoters have been identi®ed at least in mammals . The most 5' one drives the expression of two isoforms, contiguous in their 5' end but diering in their 3' region. Only the TRa1 isoform is translated in a true hormone receptor, whereas the TRa2 isoform is unable to bind thyroid hormone (T3) and thus acts as a natural dominant negative variant (Koenig et al., 1989) . In addition, an internal promoter produces trucated proteins which also act as transdominant negative . The TRb gene is transcribed from a single promoter and produces two hormone-binding isoproteins (Sakurai et al., 1992) .
The two TR genes are dierentially expressed according to the tissue considered. TRb gene expression is highly variable from one tissue to another and from one developmental stage to another (Forrest et al., 1990) . In contrast, TRa is moderately expressed in several tissues. The a1 to a2 ratio is variable, being the most contrasted in the brain (Mitsuhashi et al., 1988) . It has been suggested that the particular organization of the TRa locus contributes to the regulation of the a1/a2 balance. An orphan nuclear receptor, the Reverba gene, is indeed encoded on the opposite strand of this gene and overlaps the 3' end of the a2 isoform. Overexpression of Rev-erba could result in a downregulation of the a2 isoform and thus favor the expression of the a1 isoform (Lazar et al., 1990) .
To gain insight into the mechanisms of regulation of the expression of TRa , we cloned and characterized the human version of its promoter . We have reported that the activity of this promoter was stimulated by the synthetic glucocorticoid Dexamethasone but not by T3 or retinoic acid. Another group reported the regulation of the TRa promoter expression by p53 (Shiio et al., 1993) . Moreover, the endogenous TRa promoter is also subject to deregulation during the infection by parvoviruses . This eect is mediated by a consensus SF-1 (Steroidogenic Factor 1) responsive element (SFRE) located 7443 bp relative to the major transcription start site of the human promoter (Vanacker et al., 1996) . Moreover, we have shown that, in addition to mediating the eect of SF-1 (Wilson et al., 1993) , the SFRE is also the preferential binding site for another orphan nuclear receptor, namely the estrogen receptor related receptor, ERRa (Bonnelye et al., 1997a) . Together with ERRb, this product has been identi®ed on the basis of its structural homology to the estrogen receptor (GigueÁ re et al., 1988) .
The transcriptional activity of ERRa is a matter of controversy. It has been reported that ERRa had no eect on a single copy of the SFRE but that it could repress the retinoic acid induction of the medium-chain acyl coenzyme A dehydrogenase (MCAD) gene (Sladek et al., 1997) . ERRa also down regulates the SV40 major late promoter (Wiley et al., 1993; Johnston et al., 1997) . In contrast, we have demonstrated that ERRadependent transactivation through the SFRE is cellspeci®c (Bonnelye et al., 1997a) . Indeed, cell lines such as HeLa or NB-E support ERRa-induced SFREdependent transcriptional regulation whereas others like HepG2 or COS1 do not. Moreover, the mouse osteopontin gene promoter is transactivated by ERRa in a dose-dependent, cell-speci®c manner in various cells, including (but not only) in naturally osteopontinproducing cell lines such as ROS 17.2/8 osteosarcoma cells (Vanacker et al., submitted) . The reasons for these discrepancies are unclear.
Here we show that the TRa promoter can be upregulated by ERRa. The SFRE site present on this promoter is both necessary and sucient to mediate this eect. Moreover, in situ hybridization experiments revealed discrete territories of coexpression between TRa and ERRa during mouse embryonic development and post-natal stages. This includes such organs as heart, brown fat and intestine in the embryo and the gonads in the adult. Moreover, in the adult testis, expression of ERRa and TRa are restricted to spermatocytes I, raising the hypothesis that both receptors may be implicated in the control of the ®rst division of meiosis. Taken together, these results suggest that TRa is a molecular target of ERRa in speci®c tissues.
Results

Binding of ERRa on the TRa promoter
We have previously cloned and characterized the promoter driving the human thyroid hormone receptor alpha (TRa) gene . Analysis of the sequence of this promoter reveals the existence of a perfect consensus SF-1 responsive element (SFRE; Wilson et al., 1993) . As we have recently demonstrated, this site is also responsible for binding and activation by another nuclear orphan receptor, namely ERRa (Bonnelye et al., 1997a) . As a ®rst step in evaluation of the signi®cance of this site, we decided to compare the sequence of the human version of the TRa promoter with the rat version isolated by Lazar et al. (1994) . The rationale of this comparison is that non-coding regions are more susceptible to mutations accumulated during evolution than coding sequences. Thus, if a promoter region is conserved between species, it is probably implicated in gene regulation. Such a comparison (presented on Figure 1 ) revealed that the TCAAGGT-CA depicted in bold characters and corresponding to the SFRE site is indeed perfectly conserved between rat and human. It should also be noted that the regions¯anking the site are marginally common between the two promoters.
This result prompted us to analyse the binding capacity of ERRa on the SFRE in the TRa promoter context. To this end, competition EMSAs ( Figure 2b ) were performed in which in vitro translated ERRa protein was put in contact with the radioactively labelled probe encompassing the TRa SFRE in its promoter context (wtSFRE). Where indicated, unlabelled oligonucleotides were added as competitors (sequences given on Figure 2a ). The binding reaction produced a single DNA-protein complex, that was competed out by addition of unlabelled homologous oligonucleotide, but not by an unrelated one (unr.). Using oligonucleotides containing mutations relative to the wtSFRE as competitors, we observed that the core AGGTCA is an absolute requirement for the binding of ERRa to the SFRE. Mutations outside this sequence only slightly aect the competition potential of the oligonucleotides. Thus, ERRa speci®cally binds to the SFRE in the TRa promoter context. Since oligonucleotides M1, M2, and M6 competed for the binding of ERRa to the probe (although to a lesser extent than wtSFRE), it should be noted that ERRa tolerates a certain¯exibility toward its binding requirements for nucleotides on either sides of the core sequence.
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Figure 1 Sequence comparison of the TRa gene promoters. The human version of the TRa gene alpha promoter is presented in the upper line according to which the nucleotides are numbered, relative to the major start site S1. The rat version (Lazar et al., 1994 ) is below and nucleotides are indicated when diverging from the human gene. The perfect consensus SFRE is depicted in bold characters. The major transcription start sites (S1 and S2) are indicated by arrows. The initiator (Inr) site is underlined
Transactivation of the TRa promoter
We then decided to investigate the capacity of ERRa to regulate the expression of the TRa promoter. We have previously shown that ERRa exerts a cell-speci®c transactivation via the SFRE consensus site (Bonnelye et al., 1997a) . We thus cotransfected two dierent cell lines that were demonstrated to support ERRa-induced activation, namely human HeLa and ras-transformed rat FREJ4 ®broblasts. As shown on Figure 3b , in both cell lines, cotransfection of pTRwt-luc with varying amounts of ERRa-encoding plasmid resulted in a dosedependent enhancement of the reporter activity. We also used mutant versions of the promoter in which the SFRE was modi®ed or deleted. The use of plasmid pTRM2 or pTRM3, containing mutations inside the SFRE, resulted in a signi®cant loss of ERRa -induced transactivation, particularly in HeLa cells. This is consistent with the EMSA data presented above, in which M2 and M3 have a weaker binding capacity for ERRa (if at all for M3) than wtSFRE. Plasmid pDTRluc contains a 69 bp deletion relative to pTRwt-luc, thereby eliminating the SFRE. As seen on Figure 3B , this plasmid did not support any ERRa-dependent enhancement of reporter activity. Therefore, our data demonstrate that ERRa transactivates the human TRa promoter in a manner that is dependent on the integrity of the SFRE site.
We next examined whether the SFRE in the TRa promoter context is also sucient to confer ERRaresponse to a heterologous promoter. To this end, reporter constructs were designed in which wtSFRE or M3 oligonucleotides were cloned as trimers in front of the minimal tk promoter contained in plasmid pBL4CAT (giving rise to plasmids pwtx3-CAT and pM3x3-CAT, respectively; depicted in Figure 4a ). The resulting contructs were sequenced to verify the number and orientation of inserted oligonucleotides. These plasmids were then cotransfected in FREJ4 cells with or without a tenfold molar excess of pSG5-ERRa. As shown on Figure 4b , plasmid pwtx3-CAT was transactivated by ERRa. In contrast, this product had Altogether, our results show that the TRa SFRE is necessary and sucient to confer ERRa response.
Coexpression of ERRa and TRa in vivo
We questionned the physiological relevance of the stimulation of the TRa promoter by ERRa. We reasoned that if ERRa up-regulates the endogenous TRa, then both receptors should be present in certain tissues. Indeed, data collected in the literature indicate that TRa and ERRa are found together in some organs (GigueÁ re et al., 1988; Forrest et al., 1990; Strait et al., 1990; Bonnelye et al., 1997b; Sladek et al., 1997; Fraichard et al., 1997) . To evaluate tissue coexpression of both receptors, we performed in situ hybridizations of mouse embryonic or adult adjacent sections with probes corresponding to either ERRa or TRa. The latter probe was chosen to recognize both TRa1 and its splice variant TRa2 in order to consider all transcripts originating from the TRa upstream promoter.
We observed that both ERRa ( Figure 5a ) and TRa ( Figure 5b ) are expressed in the whole embryonic heart with the exception of the site of fusion of the bulbar ridges with the muscular part of the interventricular septum. Additionally, we noted an expression of TRa in the outer parts of the bronchi. Both receptors are also coexpressed in brown fat (Figure 5c and d) and in the third part of the duodenum (Figure 5e and f) .
Given that ERRa and TRa were described as present in the gonads (GigueÁ re et al., 1988; Jannini et al., 1994) , we also performed in situ hybridization of these tissues, collected on 9 week old mice. As shown on Figure 6a (for ERRa) and Figure 6b (for TRa), the adult ovary coexpresses both receptors, particularly in the granulosa cells. In the male, the seminiferous tubes coexpress ERRa (Figure 6c ) and TRa ( Figure 6d) . As negative controls, in situ hybridizations with sense probes corresponding to ERRa (Figure 6e) or TRa (Figure 6f ) do not yield any signi®cant signal. This clearly demonstrates the speci®city of the antisense hybridization presented on both Figures 5 and 6 . The expression in testis is clearly absent from the interstitial region. As a control, we veri®ed that this region is the predominant site of SF-1 expression (Figure 6g ), as expected (Parker and Schimmer, 1996) . TRa expression in testis is restricted to Sertoli cells before but not after puberty (Jannini et al., 1994) , where expression is only present in dividing spermatogonia (Strait et al., 1991; Francavilla et al., 1992) . The resolution used in Figure 6c and d does not allow us to distinguish between the dierent stages of germ cell maturation. We thus present on Figure 6h and i a higher magni®cation of a seminiferous tube hybridized with a antisense ERRa or TRa, respectively. Consistently, TRa-corresponding signal does not cover the entire seminiferous tube (as would be expected in the case of an expression in Sertoli cells) but is restricted to a limited number of cells corresponding to spermatocytes I (Figure 6i , compare with the Hoesch coloration presented on ®gure 6j). In agreement with our TRaERRa interrelation hypothesis, ERRa expression is also totally restricted to the very same cells ( Figure  6h ).
In summary, ERRa and TRa are coexpressed in various tissues originating from dierent organs such as the heart, brown fat, the intestine, the ovary and the testis. The coexpression is most striking in the latter organ, where the expression of both receptors in the adult is highly restricted to a given stage of germ cell maturation.
Discussion
TRa as a molecular target of ERRa
In this paper we describe the transactivation of the TRa gene promoter by the nuclear orphan receptor ERRa. A single DNA site (SFRE) present on the promoter is both necessary and sucient to mediate this eect. Apparently, contradictory results have been published concerning the nature of the transcriptional control exerted by ERRa. Reports have described a transcriptional repression of the SV40 promoter (Wiley et al., 1993; Johnston et al., 1997) or a repression of the activation induced by retinoic acid on the mediumchain acyl coenzyme A dehydrogenase (MCAD) gene (Sladek et al., 1997) . In contrast, ERRa has been shown to enhance the positive eect of the estrogen receptor (ER) on the lactoferrin promoter through a consensus SFRE site but without having any autonomous eect (Yang et al., 1996) . We have identi®ed a ®rst direct positive target of ERRa with the osteopontin gene (Bonnelye et al., 1997a; Vanacker et al., submitted) . Moreover, we have shown that ERRainduced transactivation is cell-speci®c and promoterspeci®c. In the case of TRa, transactivation by ERRa occur in at least two dierent cell types, the human HeLa and the rat FREJ4 cells. It thus appears that ERRa can exert pleiotropic transcriptional controls depending on the targeted promoter and on the cell type considered.
It should be noted that the SFRE present on the TRa promoter is a perfect consensus. Furthermore, this sequence is totally conserved between rat and man (the only species where TRa promoter sequences are published), whereas the promoter environment is not. This suggests that this site may play a crucial role in the regulation of TRa expression. In contrast, the TRb gene promoter (Sakurai et al., 1992) does not contain any SFRE, suggesting that the ERRa-induced regulation is TRa-speci®c and is not exerted on TRb. SchraÈ der et al. (1994) have demonstrated that the TRa can bind to and activate transcription as a monomer through the octameric half-site (T/C) (A/G) AGGTCA. The SFRE present in the TRa promoter ®ts with this sequence and could be a putative target for TRa autoregulation. However, in our hands, the TRa promoter expression is not stimulated by TRa whether ERRa is present or not (data not shown). This is in agreement with our earlier report stating that the TRa promoter is not regulated by T3 hormone. We conclude that the promoter and/or the cellular context could be important to observe the monomeric eect of TRa.
The mechanisms through which the TRa promoter activity is regulated have not been extensively investigated. Shiio et al. (1993) documented an activation of the TRa promoter by the p53 protein.
We have reported that the expression of this promoter is up-regulated by Dexamethasone . A putative GRE (glucocorticoid response element) has indeed been mapped on the promoter but not proved to be active. We have also demonstrated a deregulation of the TRa promoter (both endogenous and exogenously brought) in the case of parvoviral infection (Vanacker et al., , 1996 . Interestingly, this eect is mediated by the 
Speci®city of TRa to ERRa relationships
In this paper, we demonstrate coexpression of TRa and ERRa in various tissues. Given the thickness of the sections used in our in situ hybridization experiments, signals observed in adjacent sections are likely to originate from dierent cells. However the intensity and the uniformity of the labelling in certain tissues suggest that both receptors mRNAs are present in the same cells and not only in the same tissues. Taken together with the promoter data, this is thus an argument in favour of TRa being an in vivo target gene of ERRa. However, it should be noted that all the signals obtained with TRa are weaker than the ones achieved with ERRa. This is in agreement with the fact that the TRa promoter is moderately transactivated by ERRa. Nevertheless, since some tissues express ERRa without expressing TRa, and conversely, the former cannot be considered as being necessary and sucient to regulation of the latter.
In contrast, it cannot be assumed that TRa is a target of SF-1. Indeed, SF-1 binds to the SFRE embedded in the TRa promoter context and transactivates the promoter in transient cotransfection assays (data not shown). However, SF-1 has a narrow spectrum of expression, limited to steroid producing tissues (Ikeda et al., 1994; reviewed in Parker and Schimmer, 1996) . Though SF-1 and TRa can be found in common organs, they do not seem to be expressed in the same cellular types. This is particularly striking in the adult testis where SF-1 is predominantly expressed in the Leydig cells present in the interstitial region (Parker and Schimmer, 1996 ; Figure 6 of the present paper). On the contrary, we found TRa in spermatocytes I.
Amongst the embryonic tissues, TRa and ERRa expressions are here shown to occur in the heart, duodenum and brown fat. All these tissues had already been described to express TRa and moreover TRa7/7 mice exhibit delayed intestine maturation . On another hand, the importance of ERRa in brown fat function has already been recognized (Sladek et al., 1997) . It should be noted that the expression of TRa and ERRa occur not only at the foetal stage indicated in the Figure legend, but throughout embryonic development (data not shown), suggesting an extended relationship between the two receptors. This is consistent with the data documenting the expression of TRa and ERRa early in the embryonic development (Forrest et al., 1990; Bonnelye et al., 1997b) . Expression of both receptors have also been demonstrated for other tissues. For instance, TRa is present in osteoblasts (Sato et al., 1987) where it exerts pleiotropic roles in bone remodelling (Britto et al., 1994; Varga et al., 1994) . Moreover, TRa7/7 mice appear to show impaired ossi®cation, resulting in a delayed bone development . In line with this, we have demonstrated the expression of ERRa in bone cells both in vivo and in cultured cell lines and suggested its importance in the maintenance of the dierentiated osteoblastic phenotype (Bonnelye et al., 1997a) .
We have also observed a coexpression of TRa and ERRa in the adult gonads. In the female, this occurs in the granulosa cells that synthesize progesterone and estrogen. This could suggest an interference of ERRa in the regulation of these syntheses. Coexpression of both receptors is particularly striking in the testis, where the presence of both mRNAs is restricted to a de®ned stage of germinal cell maturation, namely the spermatocyte I. Results published by Jannini et al. (1994) indicated that the main site of TRa expression in young rat testis are the Sertoli cells, both in vivo and in cultured cells. However, the presence of TRacorresponding mRNA in germ cells could not be formally ruled out. After puberty, TRa1 expression decreases in the testis. On the contrary, TRa2 expression has been documented in adult (60 day old) rat in dividing spermatogonia (Strait et al., 1991; Francavilla et al., 1992) . Consistently, our experiments performed on 9 weeks old adult mice revealed the presence of a TRa-corresponding signal speci®cally in spermatocytes I. Since the probe used for our in situ hybridization commonly recognizes TRa1 and TRa2, it is thus likely that the signal obtained in testis corresponds to TRa2. Strikingly, ERRa expression in adult testis is totally restricted to the same stage of germ cell maturation. Since spermatocyte I represents a stage immediately anterior to the ®rst division of meiosis, our data suggest that both ERRa and TRa share a direct role in controlling this process and are dispensable thereafter. In support to this, TRa7/7 male mice bear severe defect in spermatogenesis (O Chassande, personal communication) .
To date, the biological roles of ERRa remain largely unknown. However, interconnection with the functions of TRa, supported by molecular data, can be speculated to occur in the tissues where we demonstrate expression of both receptors. At least in some cases, it has been shown that the intensity of the T3 response of a given tissue is directly correlated to the amount of TR present in the cells (Carnac et al., 1993) . Since ERRa stimulates the activity of the TRa promoter, we have thus an example of an orphan receptor capable, through its transcriptional activity, of modulating the physiological response to a hormone that it does not bind.
Material and methods
Plasmids and transfections
Plasmids encoding derivatives of the TRa promoter driving the luciferase reporter gene have already been described in Vanacker et al. (1996) . For concatemerization, oligonucleotides wtSFRE or M3 supplemented with¯anking BamHI and BglII recognition sites were ligated in the presence of the two restriction enzymes. Trimers were gel-puri®ed and cloned in the BamHI site of plasmid pBL4CAT (Boshart et al., 1992) . Individual clones were sequenced to ensure the number of SFRE derivatives and the appropriate orientation, respective to the transcription sense.
Cell lines were maintained in Dulbecco's modi®ed essential medium supplemented with 10% fetal calf serum. Cells were transfected by 1 mg total DNA per assay using Lipofectamine (Gibco ± BRL) in the conditions recommended by the supplier. When necessary, pSG5 plasmid was used as a carrier. Cells were lysed 48 h after transfection and assayed for luciferase or CAT activity.
EMSA
Proteins were produced using rabbit reticulocyte TNT kit (Promega). EMSAs were performed using 40610 3 c.p.m. of 32 P end-labelled oligonucleotide probe and 2 ml of in vitro synthesized proteins. Binding reactions were performed under conditions already described . Reaction products were run on a 5% native acrylamide gel.
In situ hybridization.
E13.5, E15.5 and E17.5 mouse embryos or tissues from 9 week old mice were ®xed at 48C for 16 h in 4% paraformaldehyde in phosphate-buered saline containing 5 mM MgCl 2 dehydrated and embedded in paran. Fivemm-thick sections were transferred to 3-aminopropyltriethoxysilane (TESPA; Aldrich) coated slides and dried at 428C for 2 days. In situ hybridization was performed as described (QueÂ va et al., 1992) using 35 S-labelled antisense RNA probe synthesized from a full-length mouse ERRa cDNA cloned in Bluescript II KS (Stratagene) or from a full length rat TRa cDNA cloned in pSP72 (Promega). To avoid any cross-hybridization with ERRb mRNA, hybridization was performed within stringent conditions (608C). As a negative control, adjacent sections were hybridized with 35 S-labelled sense RNA probes synthesized from the same template. At the end of the in situ hybridization protocol, nuclei were stained with bisbenzimide and appeared blue under¯uorescent light.
